Summary
Ligand-induced activation of transmembrane receptors activates intracellular signaling cascades that control vital cellular processes, such as cell proliferation, differentiation, migration and survival. Receptor signaling is modulated by several mechanisms to ensure that the correct biological outcome is achieved. One such mechanism, which negatively regulates receptor signaling, involves the modification of receptors with ubiquitin. This post-translational modification can promote receptor endocytosis and targets receptors for lysosomal degradation, thereby ensuring termination of receptor signaling. In this Commentary, we review the roles of ubiquitylation in receptor endocytosis and degradative endosomal sorting by drawing on the epidermal growth factor receptor (EGFR) as a well-studied example. Furthermore, we elaborate on the molecular basis of ubiquitin recognition along the endocytic pathway through compartment-specific ubiquitin-binding proteins and highlight how endocytic sorting machineries control these processes. In addition, we discuss the importance of ubiquitin-dependent receptor endocytosis for the maintenance of cellular homeostasis and in the prevention of diseases such as cancer.
Introduction
Ubiquitylation is a highly controlled process that labels proteins by covalent attachment of ubiquitin to lysine residues. Conjugation of ubiquitin typically occurs in a three-step process by the sequential action of ubiquitin-activating (E1), ubiquitin-conjugating (E2) and ubiquitin-ligating (E3) enzymes. This reaction leads to the formation of an isopeptide bond between the carboxyl group of the C-terminal glycine residue (Gly76) of ubiquitin and the ε-amino group of a Lys residue in or the N-terminus of the substrate (Hershko and Ciechanover, 1998; Pickart and Eddins, 2004; Varshavsky, 1997). Because ubiquitin itself contains seven lysine residues (Lys6, Lys11, Lys27, Lys29, Lys33, Lys48 and Lys63) that can serve as acceptor sites for chain elongation, chains that contain multiple ubiquitin moieties can be formed by either homotypic or heterotypic linkages (Ikeda and Dikic, 2008). Cellular proteins can thus be subject to diverse types of ubiquitin modifications: (1) monoubiquitylation, the attachment of a single ubiquitin, (2) multiple monoubiquitylation, the attachment of multiple single ubiquitin molecules to several lysine residues in the target protein, and (3) polyubiquitylation, a modification with ubiquitin chains of diverse lengths and linkages (Ikeda and Dikic, 2008). The ubiquitin modification can be reversed by the action of deubiquitylating enzymes (DUBs) that recycle ubiquitin to the cytoplasmic pool (Komander et al., 2009) [see the Commentary by Michael Clague, Judy Coulson and Sylvie Urbé in this issue (J. Cell Sci. 125, 277-286)]. Ubiquitylation is thus a highly versatile and reversible process.
Ubiquitin modifications on target proteins are recognized by an array of ubiquitin-binding domains (UBDs) that bind non-covalently to ubiquitin and which are found in a plethora of effector proteins. The formation of complex ubiquitin–UBD interaction networks controls numerous cellular processes (Dikic et al., 2009); whereas Lys48-linked polyubiquitylation labels proteins for proteasomal targeting and degradation, other forms of protein ubiquitylation control diverse cellular functions, including receptor endocytosis, endosomal sorting, NF-κB signaling and DNA repair (Bergink and Jentsch, 2009; Haglund and Dikic, 2005; Hershko and Ciechanover, 1998; Raiborg and Stenmark, 2009).
Ligand binding to transmembrane receptors induces signaling cascades that control essential cellular processes, such as cell proliferation, differentiation, migration and survival (Schlessinger, 2000). Following binding to their cognate ligands and signal initiation, many cell surface transmembrane proteins and receptors undergo endocytosis, followed by their intracellular trafficking along an endocytic path. Activated signaling receptors (such as receptor tyrosine kinases; RTKs) undergo clathrin-mediated endocytosis. In this pathway, receptors accumulate in clathrin-coated pits that pinch off from the plasma membrane into the cytoplasm through the action of the GTPase dynamin (Fig. 1) (Doherty and McMahon, 2009). Receptors can also undergo endocytosis by several clathrin-independent mechanisms (Hansen and Nichols, 2009; Mayor and Pagano, 2007). Following internalization either by clathrin-dependent or clathrin-independent endocytosis, receptors are routed to early endosomes (Sorkin and von Zastrow, 2009). Importantly, receptor signaling can occur both from the plasma membrane and endosomes (Miaczynska and Bar-Sagi, 2010; Sorkin and von Zastrow, 2009). Once located in early endosomes, receptors can either be recycled back to the plasma membrane, to allow for repeated receptor activation, or become sorted into intraluminal vesicles (ILVs) of multivesicular endosomes (MVEs), which targets them for lysosomal degradation and thereby results in termination of receptor signaling (Katzmann et al., 2001; Raiborg and Stenmark, 2009) (Fig. 1). Fidelity in endosomal receptor sorting is thus important for restricting the duration of receptor signaling and the maintenance of cellular homeostasis by preventing prolonged and excessive activation of signals downstream of the receptor that could contribute to pathologies such as cancer (Abella and Park, 2009; Bache et al., 2004; Haglund et al., 2007; Mosesson et al., 2008).
Ubiquitylation in receptor endocytosis and endosomal sorting. Following ligand binding, signaling receptors (in this example the EGFR), can undergo clathrin-mediated endocytosis (right) or clathrin-independent endocytosis (left) (Goh et al., 2010; Scita and Di Fiore, 2010; Sigismund et al., 2005). In both cases, receptors are routed to early endosomes, from where they can be sorted into ILVs of the MVE and subsequently targeted for lysosomal degradation (ubiquitylated receptors) or recycled to the plasma membrane (non-ubiquitylated receptors). As described in the main text, the contribution of ubiquitylation to EGFR endocytosis seems to depend on the experimental system used (Goh et al., 2010; Madshus and Stang, 2009; Sigismund et al., 2005). The CBL family of ubiquitin ligases has a key role in mediating RTK ubiquitylation. CBL associates with activated receptors either directly or indirectly, for example through GRB2. Ubiquitin is an essential signal for endosomal sorting of EGFRs into the ILVs of MVEs. Components of the endocytic machinery, including EPS15, epsins, the ESCRT-0 components HRS and STAM, the ESCRT-I components TSG101 and Mvb12p (in yeast) (and the novel ESCRT-I component UBAP1), the ESCRT-II component VPS36 (EAP45), as well as EPS15b and GGA3 contain ubiquitin-binding domains and have been implicated in recognizing and sorting ubiquitylated receptors either at the plasma membrane or at endosomes, as indicated in the figure. The ESCRT-I and -II components assemble in supercomplexes and have been proposed to organize buds at the endosomal membrane. The ESCRT-III complex associates with ESCRT-II and forms polymers that drive membrane scission and ILV biogenesis. DUBs catalyze the removal of ubiquitin from receptors before their translocation into the ILV, without allowing cargo to escape.
Extensive studies in the past 15 years have established the importance of receptor ubiquitylation in controlling receptor endocytosis and degradative endosomal sorting, and have identified molecular mechanisms and machineries governing these processes. In this Commentary, we will review the roles of ubiquitylation in receptor endocytosis and endosomal sorting, and provide an overview of the endocytic sorting machineries with ubiquitin-binding abilities. We will particularly draw on knowledge gained from studies of the epidermal growth factor receptor (EGFR) and other receptor tyrosine kinases. Furthermore, we will discuss how components of the endocytic sorting machinery are regulated by monoubiquitylation and highlight the importance of receptor ubiquitylation in the homeostatic control of biological processes and in malignant conditions such as cancer.
Historical overview of ubiquitylation and endocytosis
The first evidence for ubiquitin having a role in receptor endocytosis and degradative receptor sorting to the vacuole and/or lysosome came from studies of the G-protein-coupled receptor (GPCR) Ste2p and transporters (uracil permease and the ABC-transporter Ste6p) in Saccharomyces cerevisiae. In particular, monoubiquitylation of uracil permease was sufficient for its endocytosis, and Lys63-linked ubiquitin chains further stimulated the process (Galan and Haguenauer-Tsapis, 1997; Hicke and Riezman, 1996; Kolling and Hollenberg, 1994). Subsequent studies in mammalian cells have shown accordingly that fusion of ubiquitin to different types of receptors can drive their endocytosis and endosomal sorting for degradation (Haglund et al., 2003; Nakatsu et al., 2000; Raiborg et al., 2002; Strous et al., 1996).
Ubiquitylation of RTKs
Whereas the role of ubiquitylation in receptor endocytosis remains elusive for certain receptor types in mammalian cells, ubiquitylation has been established as an important signal that directs sorting of receptors into the ILVs of the MVE to target them for lysosomal degradation. In the following sections, we will focus on the role of ubiquitylation in RTK endocytosis and MVE sorting, with particular emphasis being placed on the EGFR, which is one of the most well-characterized RTKs. For a discussion of the roles of ubiquitylation in endocytosis and endosomal sorting of other types of receptors [including transforming growth factor beta (TGF-β) receptors, GPCRs and Notch receptors] and of other transmembrane proteins (channels, transporters, junctional proteins) the reader is referred to several excellent reviews that have been published recently (Hislop and von Zastrow, 2011; Kjenseth et al., 2010; Le Bras et al., 2011; Miranda and Sorkin, 2007; Moustakas et al., 2001).
Ubiquitylation in endocytosis and endosomal sorting of RTKs
RTKs constitute a large family of receptors that includes more than 50 members in humans and which have essential roles in controlling a variety of cellular and biological processes, including cell proliferation, differentiation, migration and survival (Lemmon and Schlessinger, 2010). Following their ligand-induced activation at the plasma membrane, a large number of RTKs undergo rapid ubiquitylation (Table 1). A major family of E3 ubiquitin ligases that is involved in ubiquitylation of RTKs is the family of CBL (for Cas-Br-M ecotropic retroviral transforming sequence) RING-type E3 ubiquitin ligases (Joazeiro et al., 1999; Levkowitz et al., 1999; Levkowitz et al., 1998; Thien and Langdon, 2001). In the case of the EGFR, CBL E3 ligases are either recruited directly to a specific phosphorylated tyrosine residue (Tyr1045-P) in the cytoplasmic region of the activated receptor through their tyrosine-kinase-binding (TKB) domain, or indirectly through interaction with the adaptor protein growth factor receptor-bound protein 2 (GRB2) to promote EGFR ubiquitylation at the plasma membrane (Fig. 1) (de Melker et al., 2004; Jiang et al., 2003; Schmidt and Dikic, 2005; Stang et al., 2000; Thien and Langdon, 2001). Studies aimed at elucidating the nature of ligand-induced EGFR ubiquitylation have revealed that EGFRs become modified with multiple monoubiquitin units, as well as a mixture of ubiquitin chains, predominantly Lys63-linked chains (Haglund et al., 2003; Huang et al., 2006; Mosesson et al., 2003). In the following sections, we will discuss the mechanisms by which ubiquitylation regulates endocytosis and endosomal sorting of the EGFR as a representative member of the RTK family.
Ubiquitylation and internalization of the EGFR
Clathrin-mediated endocytosis represents a major pathway for EGFR internalization, but EGFR endocytosis can also occur through clathrin-independent pathways (Fig. 1) (Goh et al., 2010; Scita and Di Fiore, 2010; Sigismund et al., 2005). The roles of ubiquitylation in EGFR endocytosis have been and are still under thorough investigation, and recent studies have indicated that the ligand concentration and extent of ubiquitylation can affect the internalization route (Sigismund et al., 2005). These findings suggest that at low doses of epidermal growth factor (EGF), ubiquitylation of the EGFR cannot be detected and that, under these conditions, receptors mainly undergo clathrin-mediated endocytosis (Sigismund et al., 2005). By contrast, higher ligand concentrations result in a substantial proportion of the receptors becoming ubiquitylated and undergoing clathrin-independent, but lipid-raft-dependent, endocytosis (Sigismund et al., 2005). The specific internalization route was found to affect EGFR fate and thus the duration of receptor signaling (Sigismund et al., 2008). EGFRs entering cells through clathrin-mediated endocytosis were not targeted for degradation but were rather recycled to the cell surface (Sigismund et al., 2008). In this way, clathrin-dependent EGFR endocytosis prolonged the duration of EGFR-activated signaling pathways and ultimately EGFR-induced biological responses (Sigismund et al., 2008). By contrast, in these studies clathrin-independent EGFR endocytosis preferentially targeted receptors for degradation (Sigismund et al., 2008; Sigismund et al., 2005). In addition to the above-mentioned reports, other recent studies have indicated that multiple mechanisms collectively control clathrin-mediated endocytosis of the EGFR (Goh et al., 2010). These mechanisms include ubiquitylation of Lys residues in the kinase domain of EGFR, interaction of the receptor with the clathrin adaptor protein (AP)-2 complex, interaction with the adaptor protein GRB2 and acetylation of C-terminal Lys residues (Goh et al., 2010). It is possible that the relative contribution of these mechanisms varies depending on the cell type and experimental conditions, that not all mechanisms are simultaneously employed by a single cell and that certain mechanisms are preferentially employed under physiological conditions. In this context, it also has to be considered that, in some studies, ubiquitylation of EGFRs is detected even at low EGF concentrations, and that ubiquitylation can promote the translocation of the receptors to clathrin-coated pits (Madshus and Stang, 2009). On the basis of these available data, the contribution of ubiquitylation to clathrin-mediated EGFR endocytosis still remains somewhat elusive and might be influenced by the exact experimental conditions used (Goh et al., 2010; Huang et al., 2007; Madshus and Stang, 2009; Sigismund et al., 2005).
Ubiquitylation in endosomal sorting of the EGFR
Following their endocytosis and trafficking to early endosomes, EGFRs can either recycle back to the plasma membrane or become sorted into the ILVs of MVEs and thereby become targeted for lysosomal degradation (Fig. 1) (Futter et al., 1996; Levkowitz et al., 1998; Longva et al., 2002). Several lines of evidence show that ubiquitylation is a signal that is required for degradative receptor sorting into MVEs and consequent lysosomal degradation (Katzmann et al., 2002; Raiborg et al., 2002; Raiborg and Stenmark, 2009). This is supported by the observation that fusion of ubiquitin to the transferrin receptor, which is normally recycled, prevents its recycling and targets it for degradative endosomal sorting (Raiborg et al., 2002). Moreover, mutant EGFRs that lack the ability to recruit CBL, and thus do not become ubiquitylated, are not targeted for lysosomal degradation and are instead rapidly recycled to the plasma membrane (Peschard and Park, 2003). Similarly, oncogenic CBL mutants, whose ubiquitin ligase activity is impaired, block EGFR degradation, and receptors are instead recycled from endosomes to the plasma membrane (Peschard and Park, 2003).
In addition, two alternative EGFR ligands, TGF-α and EGF, which have different effects on EGFR ubiquitylation also differentially affect degradation. TGF-α dissociates from the EGFR at the low pH (5.5–6.0) of early endosomes, which leads to a rapid decrease of EGFR ubiquitylation and consequent receptor recycling (Longva et al., 2002). EGF, by contrast, has a higher affinity for the EGFR and remains persistently bound to the receptor along the endocytic route, thereby favoring continued EGFR ubiquitylation and degradation (Longva et al., 2002). Indeed, following EGF stimulation, CBL remains associated with EGFRs and promotes receptor ubiquitylation along the endocytic route, thereby ensuring that the receptors are sorted to MVEs and targeted for lysosomal degradation (de Melker et al., 2001; Grovdal et al., 2004; Haglund et al., 2003; Levkowitz et al., 1998; Longva et al., 2002; Umebayashi et al., 2008). Taken together, these data support the notion that ubiquitylation of receptors, such as the EGFR, is a signal for MVE sorting and lysosomal degradation that shunts receptors away from the recycling pathway.
Ubiquitylation and endocytosis of other RTKs
Other RTKs that undergo ligand-induced ubiquitylation include the platelet-derived growth factor receptor (PDGFR) (Miyake et al., 1998; Miyake et al., 1999; Mori et al., 1992; Mori et al., 1993), the vascular endothelial growth factor receptor (VEGFR) (Duval et al., 2003; Kobayashi et al., 2004), the hepatocyte growth factor receptor (HGFR, also known as MET) (Peschard et al., 2001), the fibroblast growth factor receptor (FGFR) (Haugsten et al., 2008; Wong et al., 2002a), the colony-stimulating factor-1 receptor (CSF1R) (Lee et al., 1999; Wang et al., 1999), KIT (Masson et al., 2006; Miyazawa et al., 1994; Mori et al., 1995), RET (Scott et al., 2005), the insulin-like growth factor-type 1 receptor (IGF1R) (Vecchione et al., 2003) and the nerve growth factor (NGF) receptor NTRK1 (also known as TRK and TRKA) (Arevalo et al., 2006; Geetha et al., 2005; Geetha and Wooten, 2008; Takahashi et al., 2011) (Table 1). Ubiquitylation of all of these receptors promotes their degradation and is, at least in part, also mediated by the CBL family of ubiquitin ligases (Table 1). Ubiquitylation is not required for the endocytosis of, for example, FGFR1, but is required for its degradative endosomal receptor sorting and termination of receptor signaling (Haugsten et al., 2008). By contrast, Lys63-linked polyubiquitylation by the E3 ubiquitin-protein ligase TRAF6 is important for NTRK1 internalization, which is in turn required for receptor-induced signaling and neurite outgrowth (Geetha et al., 2005). Ubiquitylation of this receptor by both E3 ubiquitin-protein ligase NEDD4-like (NEDD4L, also known as NEDD4-2) and CBL, however, promotes receptor degradation in lysosomes and thereby termination of receptor signaling (Arevalo et al., 2006; Takahashi et al., 2011).
Importantly, RTK ubiquitylation itself is also controlled in order to fine-tune receptor signaling and downregulation. The activity of CBL ubiquitin ligases is negatively regulated by several mechanisms, such as self-ubiquitylation of CBL, which promotes its proteasomal degradation, and specific modulators that can inhibit CBL-mediated ubiquitylation, including Sprouty 2 (SPRY2), suppressor of T-cell receptor signaling 2 (STS2, also known as UBS3A and UBASH3A) and low-density-lipoprotein-related protein 1 (LRP1) (Kowanetz et al., 2004; Takayama et al., 2005; Wong et al., 2002b). Thus, robust mechanisms are in place to regulate RTK ubiquitylation, endocytosis and degradation, and ultimately control the duration of RTK activation, thereby modulating receptor signaling output.
Ubiquitin-binding proteins in endosomal receptor trafficking
The presence of UBDs within numerous compartmentalized endocytic adaptor proteins has provided insight into the molecular basis for ubiquitin-dependent trafficking of receptors along the endocytic pathway (Fig. 1, Table 2). Here, we give an overview of some of these proteins and their roles in receptor endocytosis and endosomal sorting.
Ubiquitin-binding proteins in early endocytosis
Several endocytic adaptor proteins involved in regulating the early steps of endocytosis contain UBDs. EPS15 (for EGFR substrate 15), epsin 1 (EPN1, EPS15-interacting protein 1) and epsin 2 (EPN2) interact with the clathrin adaptor AP-2 complex at the plasma membrane and participate in the assembly of clathrin-coated vesicles (Benmerah et al., 1998; Chen et al., 1998). Each of these proteins contains ubiquitin-interacting motifs (UIMs), which are able to mediate the interaction with monoubiquitin (Table 2) (Di Fiore et al., 2003; Polo et al., 2002). Knockdown of EPS15 and epsin 1 and 2 causes impairment of EGFR endocytosis (Kazazic et al., 2009; Sigismund et al., 2005; Stang et al., 2004), and an intact UIM in Ent1p, one of the yeast epsin homologues, has been shown to be required for receptor endocytosis in yeast strains that lack wild-type epsins (Ent1p and Ent2p) and EPS15 (Ede1p) (Shih et al., 2002).
Ubiquitin-binding proteins in endosomal sorting
Ubiquitin-binding proteins that reside at the limiting membrane of early endosomes participate in binding and directing ubiquitylated receptors into MVEs (Dikic et al., 2009; Raiborg and Stenmark, 2009). The endosomal sorting complex required for transport (ESCRT) machinery has major roles in the sorting of ubiquitylated cargo into MVEs and in MVE biogenesis (Hurley and Hanson, 2010; Raiborg and Stenmark, 2009; Shields and Piper, 2011). The ESCRT complex consists of four subcomplexes (0, I, II and III), which in turn comprise a number of different proteins (Fig. 1) (Hurley, 2010; Katzmann et al., 2002; Raiborg and Stenmark, 2009; Shields and Piper, 2011; Wollert and Hurley, 2010). ESCRT-0, which consists of HRS [hepatocyte growth factor-regulated tyrosine kinase substrate, also known as HGS and, in yeast, vacuolar protein sorting (Vps) 27p] and STAM (signal-transducing adaptor molecule; Hse1p in yeast), is recruited to endosomal membranes through the interaction of the HRS FYVE domain with phosphatidylinositol 3-phosphate [PtdIns3P] (Burd and Emr, 1998; Gaullier et al., 1998; Raiborg et al., 2001b). ESCRT-0 has the ability to recruit the ESCRT-I complex [which is made up of TSG101 (tumor susceptibility gene 101; Vps23p in yeast), VPS28, VPS37 and MVB12 (multivesicular body subunit 12, also known as FAM125A) (Chu et al., 2006; Katzmann et al., 2001; Kostelansky et al., 2007; Morita et al., 2007; Oestreich et al., 2007; Stuchell et al., 2004)] through an interaction between HRS and TSG101 (Bache et al., 2003; Katzmann et al., 2003; Lu et al., 2003). ESCRT-I and ESCRT-II, which comprise a single VPS36 (also known as EAP45), a single VPS22 and two VPS25 subunits, can form a supercomplex through interactions between VPS28 and VPS36 (also see below) (Gill et al., 2007; Im and Hurley, 2008). ESCRT-II can interact with ESCRT-III [comprising CHMP6 (VPS20), CHMP4A (VPS32), CHMP3 (VPS24) and the CHMP2 (VPS2) subunits]. In a model for ILV formation at the MVE, ESCRT-I and ESCRT-II form buds that subsequently are cut by membrane scission catalyzed by the polymer formed by the ESCRT-III complex (Hanson et al., 2008; Hurley, 2010; Im et al., 2009; Raiborg and Stenmark, 2009; Wollert and Hurley, 2010; Wollert et al., 2009).
Several of the subunits of the ESCRT machinery contain UBDs and accumulating evidence suggests that these allow the ESCRT machinery to capture and sort ubiquitylated receptors into MVEs (Fig. 1, Table 2) (Dikic et al., 2009; Hurley and Stenmark, 2011; Raiborg and Stenmark, 2009; Shields and Piper, 2011). The ESCRT-0 complex contains several UBDs: HRS contains one double-sided UIM and one VHS (VPS27, HRS, STAM) domain (yeast Vps27p contains two UIMs), and STAM (yeast Hse1p) contains one UIM and one VHS domain (Table 2). Convincing evidence in both yeast and mammalian cells suggests that ESCRT-0 can recognize and sort ubiquitylated cargo at endosomes, because loss of the UBDs in the yeast ESCRT-0 or of the UIM of mammalian HRS causes defects in capturing and sorting of ubiquitylated cargo (Bilodeau et al., 2002; Hirano et al., 2006; Raiborg et al., 2002; Ren and Hurley, 2010; Urbe et al., 2003). Ubiquitylated cargo was originally thought to be sorted sequentially from ESCRT-0 to ESCRT-I and subsequently to ESCRT-II. However, recent studies suggest a model in which ESCRT-0 can recognize ubiquitylated cargo and recruit it to an ESCRT-I–ESCRT-II supercomplex that contains multiple UBDs with the ability to cooperatively recognize and coordinate sorting of ubiquitylated cargo into ILVs (Gill et al., 2007; Hurley and Hanson, 2010; Im and Hurley, 2008; Shields et al., 2009; Shields and Piper, 2011). The ESCRT-I subunit TSG101 contains a UEV (ubiquitin-conjugating enzyme E2 variant) domain and yeast Mvb12p of ESCRT-I also contains a UBD with the ability to interact with ubiquitin and sort ubiquitylated cargo (Table 2) (Shields et al., 2009; Sundquist et al., 2004; Teo et al., 2004). Moroever, a newly discovered ESCRT-I component, ubiquitin-associated protein 1 (UBAP1), contains two ubiquitin-associated domains (UBAs) that interact with ubiquitin and are required for ubiquitin-dependent endosomal sorting of EGFRs (Stefani et al., 2011). UBAP1 contains a UMA (for UBAP1-MVB12-associated) domain that is conserved in MVB12 and has been suggested to be part of an endosome-specific ESCRT-I complex (Stefani et al., 2011). The VPS36 subunit of ESCRT-II contains a ubiquitin-binding GLUE (for Gram-like ubiquitin binding in EAP45) domain and the yeast homologue Vps36p, contains two Npl4 zinc finger (NZF) domains, one of which binds ubiquitin (Alam et al., 2004; Slagsvold et al., 2005). Thus, taken together, ESCRT-0, -I and -II contain an array of UBDs that are involved in capturing and sorting ubiquitylated cargo into the ILVs of MVEs (Table 2). As described above, the ESCRT-III complex subsequently completes ILV biogenesis by membrane scission. Before receptor translocation into the ILV of the MVE, ubiquitin is removed from receptors by DUBs. This ensures that ubiquitin molecules are recycled to maintain cellular ubiquitin levels, without allowing cargo to escape (Clague and Urbe, 2006).
A number of additional ubiquitin-binding proteins present at endosomes are able to participate in degradative sorting of ubiquitylated cargo. The endosome-localized isoform of EPS15, EPS15b, associates with ESCRT-0, contains two UIMs and participates in sorting of activated EGFRs for degradation (Roxrud et al., 2008). Moreover, GGA (for Golgi-localized, gamma ear-containing, Arf-binding protein) proteins and TOM1 (target of myb1), which associate with ESCRT-I, are candidate proteins for alternative ESCRT-0 complexes, because they sort ubiquitylated cargo and, similar to ESCRT-0, contain UBDs, namely, GAT (GGA and TOM1) and VHS domains, as well as clathrin-binding domains (Table 2) (Katoh et al., 2004; Puertollano and Bonifacino, 2004; Yamakami et al., 2003). The molecular modes of action and structural details of the ubiquitin-binding proteins at endosomes are still under thorough investigation.
Endocytic adaptor proteins with ubiquitin-binding domains
Mechanisms of ubiquitin recognition during endocytic trafficking
The UBDs in the endocytic proteins discussed above all have low affinity for ubiquitin in vitro (i.e. their dissociation constants lie in the micromolar range; Table 2) (Dikic et al., 2009). Appropriate sorting of ubiquitylated cargo in vivo might be accomplished by increasing the avidity for ubiquitin through multivalent interactions, by increasing the local concentration of ubiquitylated cargoes and through the presence of multiple ubiquitin moieties attached to the cargo (Dikic et al., 2009). For example, the UIM of HRS forms a double-sided α-helix with two ubiquitin-binding surfaces, which bind two ubiquitin moieties with equal affinity, and the ESCRT complexes have the ability to form supercomplexes containing several UBDs, as described above (Hirano et al., 2006; Shields and Piper, 2011). In addition to promoting efficient ubiquitin interaction, HRS has the ability to increase the local concentration of cargo in microdomains on sorting endosomes by capturing cargo in flat clathrin coats that are assembled as a result of HRS interacting with PtdIns3P and clathrin (Raiborg et al., 2002; Raiborg et al., 2001a; Raiborg et al., 2001b; Sachse et al., 2002). A prominent example of cargo that is ubiquitylated on multiple sites is EGFR, which becomes modified with Lys63-linked polyubiquitin chains and multiple monoubiquitin modification following ligand stimulation (Haglund et al., 2003; Huang et al., 2006; Mosesson et al., 2003). Interestingly, certain UBDs have been shown to have a considerably increased affinity for Lys63-linked polyubiquitin chains compared with that for monoubiquitin, and this selectivity might be important during EGFR sorting (Dikic et al., 2009; Ren and Hurley, 2010). The UBDs in the endocytic proteins described above all bind the hydrophobic patch of ubiquitin around Ile44, and could thus compete for the binding to ubiquitylated cargo (Dikic et al., 2009). The fact that the interactions are of low affinity might allow transfer from one UBD-containing protein to another. Thus, overall, sorting of ubiquitylated receptors along the endocytic pathway to target them for lysosomal degradation is coordinated by the action of an array of compartmentalized UBD-containing endocytic adaptor proteins.
Monoubiquitylation of endocytic proteins
Several UBD-containing proteins involved in endocytosis are themselves monoubiquitylated through a process that is dependent on their UBDs and is referred to as coupled monoubiquitylation (Fig. 2). Endocytic proteins known to undergo coupled monoubiquitylation include EPS15, EPS15R, epsin 1, epsin 2, HRS, STAM, RABGEF1 (also known as RABEX5; Vps9p in yeast) as well as STS1 and STS2 (also known as UBASH3B and UBASH3A) (Hoeller et al., 2006; Katz et al., 2002; Klapisz et al., 2002; Oldham et al., 2002; Polo et al., 2002; Urbe et al., 2003) and for many of them this process takes place following the stimulation of cells with growth factors (Di Fiore et al., 2003; van Delft et al., 1997). Curiously, UBD-containing proteins lose their ability to interact with ubiquitin once they become monoubiquitylated, and this has been suggested to result from intramolecular interactions between the UBD and the covalently attached monoubiquitin moiety on the same molecule (Fig. 2) (Hoeller et al., 2006). Interestingly, coupled monoubiquitylation of UBD-containing proteins can be mediated independently of an E3 ubiquitin ligase but in a manner that requires the UBDs of these proteins (Fig. 2) (Hoeller et al., 2007). Alternatively, the UBD can recruit a monoubiquitylated E3 ubiquitin ligase or interact with a ubiquitin-like domain within the E3 ligase, which in turn mediates monoubiquitylation of the UBD-containing protein, as has been shown for NEDD4- and Parkin-mediated monoubiquitylation of EPS15, respectively (Fig. 2) (Fallon et al., 2006; Woelk et al., 2006).
Mechanisms of coupled monoubiquitylation of UBD-containing proteins. (A) A monoubiquitylated HECT-type E3 ubiquitin ligase (e.g. NEDD4) can interact with the UBD of a UBD-containing endocytic adaptor (e.g. EPS15). The HECT E3 ubiquitin ligase subsequently transfers the thiolester-conjugated ubiquitin molecule to a lysine residue in the UBD-containing protein, which thereby becomes monoubiquitylated. (B) Similarly, the ubiquitin-like (UBL) domain of a RING-type ubiquitin ligase (e.g. parkin) can interact with the UBD of a UBD-containing endocytic adaptor (e.g. EPS15). The RING E3 ubiquitin ligase then mediates monoubiquitylation of a lysine residue of the UBD-containing protein by transferring ubiquitin from an E2-conjugating enzyme to the substrate. (C) A ubiquitin-charged E2-conjugating enzyme can interact directly with the UBD of the endocytic adaptor, which leads to the direct transfer of ubiquitin from the E2 to a lysine residue in the substrate. Following coupled monoubiquitylation by one of these three mechanisms, the UBD of the endocytic adaptor can interact with the monoubiquitin attached to itself, leading to an intramolecular interaction that might alter the function and localization of the UBD-containing protein and possibly affect its ability to interact with ubiquitylated cargo during endosomal trafficking.
Functional consequences of coupled monoubiquitylation are now being elucidated, and numerous studies indicate that this modification can negatively regulate protein function during endosomal receptor trafficking (Fig. 2). For example, an EPS15–ubiquitin chimera, created by fusion of ubiquitin to the C-terminus of EPS15 to mimic its permanent monoubiquitylation, fails to localize properly to EGFR-positive endosomes and does not interact with ubiquitylated EGFRs, and thus does not promote efficient EGFR endocytosis and degradation (Fallon et al., 2006; Hoeller et al., 2006). Moreover, an HRS–ubiquitin chimera loses its ability to recognize and sort ubiquitylated cargo (Hoeller et al., 2006). A scenario that is functionally equivalent to the mechanism that inactivates HRS through monoubiquitylation was recently described for the FYVE-domain-containing negative regulator of EGFR signaling, ZFYVE28 (for zinc finger FYVE domain-containing 28, also known as LST2). Non-ubiquitylated ZFYVE28 localizes to PtdIns3P-positive endosomes through its FYVE domain and promotes degradative endosomal receptor sorting (Mosesson et al., 2009). However, monoubiquitylation of ZFYVE28 inhibits its endosomal localization and thereby its ability to target EGFRs for lysosomal degradation (Mosesson et al., 2009). Similarly, the guanine exchange factor for RAB5, RABGEF1, which cooperates with RAB5 to control endosomal fusion and contains two UBDs, fails to localize to endosomes following its monoubiquitylation, which results in defective endosomal cargo trafficking (Mattera and Bonifacino, 2008). Another example is provided by the UBA-domain-containing inhibitor of RTK endocytosis, STS2. An STS2–ubiquitin chimera was found to be substantially less active than its wild-type counterpart in stabilizing activated EGFRs, whereas an STS2 mutant lacking the ubiquitin acceptor site was more active (Hoeller et al., 2006).
Taken together, these studies indicate that covalent attachment of monoubiquitin to UBD-containing endocytic regulators can have an autoinhibitory effect by influencing the localization and/or function of these proteins during receptor endocytosis and sorting. It has to be taken into account that many of these studies were performed with chimeric proteins and that these mechanisms might not apply to all monoubiquitylated proteins. The physiological consequences of coupled monoubiquitylation need to be further studied using mutant proteins lacking the ubiquitin acceptor sites. Nevertheless, it is possible that coupled monoubiquitylation represents a molecular mechanism that can promote the transfer of ubiquitylated cargo between different UBD-containing endocytic proteins during endosomal receptor trafficking along the endocytic pathway.
Biological importance of receptor ubiquitylation
During development and adult life of multicellular organisms, intercellular communication and signal transmission through cell surface receptors, including RTKs, are tightly controlled in order to provide fidelity in cellular, biological and physiological processes (Schlessinger, 2000; Yarden and Sliwkowski, 2001). A remarkable example of modulation of RTK signaling by endocytosis occurs during Drosophila melanogaster oogenesis, when a cluster of cells, called the border cells, undergoes directed migration that is dependent on signals by two major RTKs, the EGFR and the PDGF- and VEGF-receptor related (PVR) protein (Rorth, 2009). During this process, regulators of endocytosis, such as CBL (and its ubiquitin ligase activity) and RAB5, as well as regulators of recycling (e.g. RAB11) are involved in maintaining localized RTK signaling to promote guided cell migration. This emphasizes the importance of RTK endocytosis for fine-tuning receptor signals in vivo (Assaker et al., 2010; Jekely et al., 2005). Moreover, recent studies indicate that CBL controls endocytic sorting of FGF8 and thus controls morphogen gradient interpretation during embryonic development in zebrafish (Nowak et al., 2011). The importance of accurate RTK signaling is also highlighted by the fact that uncontrolled RTK signaling, caused by, for example, activating RTK mutations or deletions, RTK overexpression or autocrine growth factor loops, have been associated with a variety of diseases, such as developmental syndromes and cancer (Abella and Park, 2009; Lemmon and Schlessinger, 2010; Wesche et al., 2011; Witsch et al., 2010).
Accumulating evidence also suggests that defects in the machinery that controls negative regulation of RTKs by ubiquitylation and receptor endocytosis and endosomal sorting might contribute to constitutive RTK signaling (Abella and Park, 2009; Bache et al., 2004; Haglund et al., 2007; Mosesson et al., 2008). Mutations in components of this machinery have indeed been implicated in carcinogenesis. For example, mutations of either CBL-binding sites in RTKs or mutations of CBL that abolish its ubiquitin ligase activity, have been reported in many oncogenic forms of both RTKs and CBL, and these result in defective CBL-mediated receptor downregulation (Haglund et al., 2007; Peschard and Park, 2003). Moreover, it has been shown that interfering with regulators of endocytosis and endosomal sorting, including components of the ESCRT machinery, causes the accumulation of ubiquitylated receptors, increased receptor signaling and tumor overgrowth in Drosophila melanogaster, and mutations in components of the endocytic machinery have been detected in human tumors (Abella and Park, 2009; Bache et al., 2004; Haglund et al., 2007; Hariharan and Bilder, 2006; Mosesson et al., 2008; Vaccari and Bilder, 2009). Taken together, these findings highlight the importance of accurate ubiquitin-mediated degradative endosomal receptor sorting for maintaining of cellular homeostasis.
Conclusions and perspectives
Since the discovery of ubiquitin as a signal that governs endocytic receptor trafficking, ubiquitylation has emerged as a major post-translational modification that controls downregulation and degradative endosomal sorting of diverse types of receptors and transmembrane proteins. Among the multiple types of possible ubiquitin modifications, three major types have been shown to modify receptors: monoubiquitylation, multiple monoubiquitylation and Lys63-linked polyubiquitylation. A key challenge will be to elucidate the functional roles of the different types of ubiquitin modifications during receptor endocytosis and endosomal sorting, and to characterize the identity, contribution and function of ubiquitin modifications for different types of receptors and in response to specific cellular stimuli. In the case of EGFR, mass spectrometry has been crucial in revealing both the relative contribution, and to identity the different types, of its ubiquitin modifications in response to EGF stimulation (Huang et al., 2006), and further insight into the potential role of Lys63-linked ubiquitin chains in MVE sorting will be of great importance (Barriere et al., 2006; Lauwers et al., 2009; Paiva et al., 2009; Ren and Hurley, 2010).
During the last decade, different machineries that are responsible for ubiquitin-dependent receptor trafficking, including the ESCRT machinery and various UBD-containing endocytic adaptor proteins have been identified. Furthermore, functional and structural studies have given essential insight into the molecular mechanisms of ubiquitin-dependent membrane trafficking (Dikic et al., 2009; Hurley and Stenmark, 2011; Raiborg and Stenmark, 2009). However, in order to increase further the understanding of the specificity of these processes, structural studies in the context of full-length ubiquitylated cargo are needed. Moreover, increased insight into the dynamics of sorting of ubiquitylated cargo along the endocytic pathway is required. For example, we still do not fully understand how cargo can be transferred between different ubiquitin-binding proteins along the endocytic route, how multivalent interactions contribute to cargo sorting, to what extent monoubiquitylation of UBD-containing proteins participates in this process and how the emerging cross-talk between E3 ubiquitin ligases, DUBs and ubiquitin-binding proteins can affect receptor trafficking. As the field is currently developing at great speed, there is no doubt that exciting discoveries and novel insight into these and other fundamentally important issues concerning ubiquitin-dependent receptor trafficking will be gained in the near future.
Acknowledgements
We apologize to investigators whose important contributions were not included in this review owing to space limitations. We thank Harald Stenmark for critical reading of the manuscript.
Footnotes
-
This article is part of a Minifocus on Ubiquitin. For further reading, please see related articles: ‘Ubiquitin and SUMO in DNA repair at a glance’ by Helle D. Ulrich (J. Cell Sci. 125, 249-254). ‘Emerging regulatory mechanisms in ubiquitin-dependent cell cycle control’ by Annamaria Mocciaro and Michael Rape (J. Cell Sci. 125, 255-263). ‘Cellular functions of the DUBs’ by Michael J. Clague et al. (J. Cell Sci. 125, 277-286). ‘HECT and RING finger families of E3 ubiquitin ligases at a glance’ by Meredith B. Metzger et al. (J. Cell Sci. 125, 531-537). ‘Non-canonical ubiquitin-based signals for proteasomal degradation’ by Yelena Kravtsova-Ivantsiv and Aaron Ciechanover (J. Cell Sci. 125, 539-548). ‘No one can whistle a symphony alone – how different ubiquitin linkages cooperate to orchestrate NF-κB activity’ by Anna C. Schmukle and Henning Walczak (J. Cell Sci. 125, 549-559).
-
Funding
K.H. acknowledges support from the Research Council of Norway and I.D. from the Deutsche Forschungsgemeinschaft.
- © 2012.
References
Article navigation
- Top
- Article
- Summary
- Introduction
- Historical overview of ubiquitylation and endocytosis
- Ubiquitylation in endocytosis and endosomal sorting of RTKs
- Ubiquitin-binding proteins in endosomal receptor trafficking
- Monoubiquitylation of endocytic proteins
- Biological importance of receptor ubiquitylation
- Conclusions and perspectives
- Acknowledgements
- Footnotes
- References
- Figures & tables
- Info & metrics
Related articles
Cited by...
More in this TOC section
Similar articles
Subject collections
Other journals from The Company of Biologists
2020 at The Company of Biologists
Despite the challenges of 2020, we were able to bring a number of long-term projects and new ventures to fruition. While we look forward to a new year, join us as we reflect on the triumphs of the last 12 months.
Mole – The Corona Files
"This is not going to go away, 'like a miracle.' We have to do magic. And I know we can."
Mole continues to offer his wise words to researchers on how to manage during the COVID-19 pandemic.
Cell scientist to watch – Christine Faulkner
In an interview, Christine Faulkner talks about where her interest in plant science began, how she found the transition between Australia and the UK, and shares her thoughts on virtual conferences.
Read & Publish participation extends worldwide
“The clear advantages are rapid and efficient exposure and easy access to my article around the world. I believe it is great to have this publishing option in fast-growing fields in biomedical research.”
Dr Jaceques Behmoaras (Imperial College London) shares his experience of publishing Open Access as part of our growing Read & Publish initiative. We now have over 60 institutions in 12 countries taking part – find out more and view our full list of participating institutions.
JCS and COVID-19
For more information on measures Journal of Cell Science is taking to support the community during the COVID-19 pandemic, please see here.
If you have any questions or concerns, please do not hestiate to contact the Editorial Office.